Navigation Links
Lower back pain and surgery

Rosemont, Ill. A literature review, led by Dr. Joseph Lee, published in the June 2010 issue of the Journal of the American Academy of Orthopaedic Surgeons (JAAOS) suggests that a herniated disk is one of the most frequent causes of low back and leg pain in adults, but surgery is not for everyone. Between 60 and 80 percent of people will experience low back pain at some point in their lives

Disks, which are strong shock absorbers between the vertebrae, can begin to herniate or weaken when their jelly-like nucleus pushes against the outer ring due to aging or a sudden injury. This pressure against the outer ring is often what causes lower back pain.

"Orthopaedic surgeons can help by educating patients about the risks of back surgery and work with the patient to determine the best course of treatment, whether it be surgical or non-surgical," stated review co-author Mark Weidenbaum, MD, Director of Orthopaedic Spine Surgery, Department of Orthopaedic Surgery, New York-Presbyterian Hospital-Milstein Pavilion, Columbia University Medical Center, New York.

A herniated disk can sometimes be very painful and most people feel better with just a few months of nonsurgical treatment, which can consist of physical therapy, medications or epidural steroids. However, some patients are treated with a surgical procedure known as a diskectomy.

At least 200,000 diskectomies are performed in the United States each year, and potential diskectomy surgical techniques include:

  • conventional open diskectomy ;
  • micro-diskectomy; which is the most common technique
  • minimally invasive (endoscopic) diskectomy; and
  • open diskectomy with fusion.

"The main thing for patients who may be contemplating surgery for back pain is that it must be a mutual decision agreed upon by both doctor and patient. Both parties need to discuss the type of disk herniation and all the potential options for treatment before deciding on surgery," suggested Dr. Weidenbaum.

Many patients find relief after a diskectomy, but approximately 5 percent to 15 percent of patients experience a recurrent disk herniation, defined as back and/or leg pain recurring after a definite pain-free period from the initial surgery, then pain begins again. Treatment for recurrent lumbar disk herniation may include aggressive medical management and surgical intervention.

In addition, the review cited literature indicated that:

  • Patients with larger herniations are more likely to experience a recurrence of pain; and
  • Patients who had endoscopic surgery (less invasive) may be more likely to experience a recurrence than patients who had a more invasive procedure.

"When a patient has recurring pain, surgeons should perform a complete workup, including an MRI, to learn whether the cause is actually recurrent disk herniation or another problem, such as spinal instability," Weidenbaum notes. "If a patient has spinal instability a revision diskectomy isn't going to help that personanother type of surgery may be needed."


Contact: Lauren Pearson
American Academy of Orthopaedic Surgeons

Related medicine news :

1. Risk of stroke lower for recent Ontario immigrants: study
2. Immigrants at Lower Stroke Risk Than Long-Term Residents?
3. Consumer Reports Health: Many Hospitals Fail To Lower Infection Risk Despite Lifesaving Checklist
4. Study Finds Ponseti Method of Clubfoot Correction Leads to Lower Surgical Rates and Less Revision Surgery
5. Mortality rates for pediatric rheumatology patients significantly lower than previously reported
6. News brief: Childhood survivors of CNS cancers and leukemia have lowered educational attainment
7. One Type A Trait May Actually Lower Work Stress
8. For Lower Blood Pressure, Low-Carb Diet May Be Best
9. Fast food menus with calorie information lead to lower calorie selections for young children
10. Research Indicates Participants in Incentive-Based Health Promotion Programs Have Lower Healthcare Costs
11. has Recently Swept Through Their Site and Lowered Prices Even Further On Thousands of Products
Post Your Comments:
(Date:12/1/2015)... NY (PRWEB) , ... December 01, 2015 , ... ... non-traumatic limb amputations in the United States. Podiatrists are well aware that psychology-based ... adopt therapeutic behaviors) are often catastrophic contributors to diseases of the diabetic foot. ...
(Date:12/1/2015)... ... December 01, 2015 , ... For the ... is why Hollister Incorporated has launched the VaPro Plus Pocket™ touch free hydrophilic ... the VaPro touch free catheter portfolio,” said Michael Gresavage, Vice President North America. ...
(Date:12/1/2015)... ... December 01, 2015 , ... Next IT Healthcare, the leader ... in this year’s Fierce Innovation Awards: Healthcare Edition, an awards program from the ... finalist in the category of Digital Solutions for its innovative, industry-leading product, Alme ...
(Date:12/1/2015)... ... 2015 , ... TCS Healthcare Technologies (TCS), a leading provider ... is pleased to announce that VIP Care Services, a Caprock Health Group affiliate ... Complete Care™ Management to back their collaborative catastrophic case management initiatives. ACUITY Complete ...
(Date:12/1/2015)... GA (PRWEB) , ... December 01, 2015 , ... ... supports SACC-GA and SACC-USA through membership and leadership since 2008. Gary ... Chair for SACC-USA . Gary has spent a significant amount of time ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... BOSTON , December 1, 2015 Russia ... phase III clinical trials. 70% of new drugs registered in ... trials in Russia . --> Russia has ... trials. 70% of new drugs registered in Europe ... . --> Russia has always been ...
(Date:12/1/2015)... , Dec. 1, 2015 Relmada Therapeutics, Inc. ... treatment of chronic pain, announced today that the company will ... be held December 1-3 at the Luxe Sunset Boulevard Hotel ... Traversa , CEO of Relmada Therapeutics, will present on Thursday, ... Time). . Please register at least 10 ...
(Date:12/1/2015)...   MabVax Therapeutics Holdings, Inc . (OTCQB: MBVX), ... filed an Investigational New Drug Application (IND) with the ... lead fully human antibody product HuMab 5B1 as a ... initiate the Phase I clinical trial early in 2016. ... The planned Phase I trial will evaluate the safety, ...
Breaking Medicine Technology: